Search results for MAVS Antibody

Anti-MAVS antibody [EPR26357-91], Abcam, AB290729

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-MAVS antibody [EPR28262-28], Abcam, AB314444

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-MAVS antibody - N-terminal, Abcam, AB189303

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody, Abbexa, abx211844

MAVS Antibody is a Rabbit Polyclonal against MAVS.

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody, Abbexa, abx405632

This product is currently in development. The lead time for this product may be several months. Please contact us at [email protected] for an updated lead time before purchasing this product. Mouse Mitochondrial Antiviral Signaling Protein (MAVS) Antibody is a Rabbit polyclonal against Mitochondrial Antiviral Signaling Protein (MAVS).

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody, Abbexa, abx113766

Mitochondrial Antiviral Signaling Protein Antibody is a Rabbit Polyclonal antibody against Mitochondrial Antiviral Signaling Protein.

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody, Abbexa, abx004412

MAVS Antibody is a Rabbit Polyclonal antibody against MAVS. This gene encodes an intermediary protein necessary in the virus-triggered beta interferon signaling pathways. It is required for activation of transcription factors which regulate expression of beta interferon and contributes to antiviral immunity. Multiple transcript variants encoding different isoforms have been found for this gene.

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody, Abbexa, abx240064

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody is a Rabbit Polyclonal antibody for the detection of MAVS. Required for innate immune defense against viruses. Acts downstream of DDX58/RIG-I and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFN-beta and RANTES (CCL5). Peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. May activate the same pathways following detection of extracellular dsRNA by TLR3. May protect cells from apoptosis.It can undergoe phosphorylation on multiple sites and ubiquitination, which may together cause the molecular weight migrate to about 70 kDa despite the predicated 57 kDa.

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody, Abbexa, abx027604

Double-stranded RNA viruses are recognized in a cell type-dependent manner by the transmembrane receptor TLR3 (MIM 603029) or by the cytoplasmic RNA helicases MDA5 (MIM 606951) and RIGI (ROBO3; MIM 608630). These interactions initiate signaling pathways that differ in their initial steps but converge in the activation of the protein kinases IKKA (CHUK; MIM 600664) and IKKB (IKBKB; MIM 603258), which activate NFKB (see MIM 164011), or TBK1 (MIM 604834) and IKKE (IKBKE; MIM 605048), which activate IRF3 (MIM 603734). Activated IRF3 and NFKB induce transcription of IFNB (IFNB1; MIM 147640). For the TLR3 pathway, the intermediary molecule before the pathways converge is the cytoplasmic protein TRIF (TICAM1; MIM 607601). For RIGI, the intermediary protein is mitochondria-bound IPS1 (Sen and Sarkar, 2005 [PubMed 16239922]).

Mitochondrial Antiviral Signaling Protein (MAVS) Antibody, Abbexa, abx322215

MAVS Antibody is a Rabbit Polyclonal against MAVS.